Justifying Organ Allocation Out of Sequence

Andrew Courtwright1

  • 1University of Utah Hospital.

Insights

Allocation Out of Sequence (AOOS) in organ transplantation is rising, raising ethical concerns. This study examines AOOS factors and argues it violates procedural justice, necessitating policy revision for legitimacy.

Area of Science:

  • Medical Ethics
  • Transplantation Medicine
  • Health Policy

Background:

  • Allocation Out of Sequence (AOOS) is increasingly prevalent in US organ transplantation, with 20% of kidneys transplanted outside the standard sequence by end-2024.
  • AOOS faces criticism for failing to prevent organ nonuse, address allocation inefficiencies, ensure transparency, and potentially worsening transplant disparities.

Purpose of the Study:

  • To outline factors contributing to the expansion of AOOS in organ transplantation.
  • To evaluate the ethical and normative arguments for and against AOOS.
  • To propose considerations for revising AOOS policies based on procedural justice.

Main Methods:

  • Review of ethical concerns and regulatory scrutiny surrounding AOOS.
  • Analysis of normative arguments for and against AOOS.
  • Application of a constructivist framework to assess AOOS against principles of procedural justice.

Main Results:

  • AOOS expansion is driven by various factors, though specific drivers are not detailed.
  • The primary ethical critique of AOOS centers on violations of procedural justice.
  • AOOS conflicts with the principle that allocation policies should stem from collective agreement.

Conclusions:

  • AOOS undermines procedural legitimacy in organ allocation.
  • Revisions to the AOOS pathway are needed.
  • Establishing shared norms is crucial for ensuring the legitimacy of organ allocation policies.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
345
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
925
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
320